Storing refrigerated patient kits worldwide presents a growing challenge due to the increasing importance of biological drugs. Biologic agents will continue to outpace overall pharmaceutical industry spending growth and are expected to represent 19-20% of the total market value by 2017, according to IMS Health.
Fisher Clinical Services supports clinical trials of cold chain products with a wide range of refrigerated and frozen warehousing capabilities. The primary goal of our cold chain storage operation is to protect patients from unsafe study medicines by minimizing the risk of temperature excursions.
Tightly controlled environments include several layers of security, emergency backup and fire protection systems. Redundant facilities, 24-hour monitoring and alarms, as well as best practices for cold chain supply management help ensure the identity, strength, quality, and purity of investigational drugs.